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Abstract. The NPXY sequence is highly conserved 
among integrin 13 subunit cytoplasmic tails, suggesting 
that it plays a fundamental role in regulating integrin- 
mediated function. Evidence is provided that the 
NPXY structural motif within the 133 subunit, compris- 
ing residues 744-747, is essential for cell morphological 
and migratory responses mediated by integrin av133 in 
vitro and in vivo. Transfection of CS-1 melanoma cells 
with a cDNA encoding the wild-type integrin 133 sub- 
unit, results in de novo e~v133 expression and cell attach- 
ment, spreading, and migration on vitronectin. CS-1 
cells expressing t~v133 with mutations that disrupt the 
NPXY sequence interact with soluble vitronectin or an 
RGD peptide, yet fail to attach, spread, or migrate on 
immobilized ligand. The biological consequences of 
these observations are underscored by the finding that 
CS-1 cells expressing wild-type o~v133 acquire the capac- 
ity to form spontaneous pulmonary metastases in the 
chick embryo when grown on the chorioallantoic mem- 
brane. However, migration-deficient CS-1 cells ex- 
pressing av[33 with mutations in the NPXY sequence 
lose this ability to metastasize. These findings demon- 
strate that the NPXY motif within the integrin 133 
cytoplasmic tail is essential for uv133-dependent post- 
ligand binding events involved in cell migration and the 
metastatic phenotype of melanoma cells. 
C 
ELL adhesion and migration play a central role in 
diverse biological and  pathological  processes in- 
cluding embryogenesis, angiogenesis, wound heal- 
ing, and metastasis. Although the mechanisms that regu- 
late cell adhesion and motility are poorly understood, it is 
clear that in many instances, these events are initiated by 
the specific recognition of extracellular matrix proteins by 
a family of cell surface adhesion receptors known as inte- 
grins (Ruoslahti, 1991; Hynes, 1992). Upon ligand recogni- 
tion, integrins typically cluster at the site of ceU-substrate 
interface; this leads to polymerization of the actin  cyto- 
skeleton (Burridge et al., 1988). In this context, integrins 
form a physical linkage between the extracellular matrix 
and the actin cytoskeleton. Ultimately, these integrin-initi- 
ated adhesive interactions can lead to gross changes in cel- 
lular morphology orchestrated by the actin cytoskeleton 
that facilitate cell migration. 
Structurally,  integrins  are  heterodimers  composed  of 
noncovalently associated a  and [3 subunits (Hynes, 1992). 
Each  subunit  contains  a  single  transmembrane  domain 
that separates a large ectodomain from its cytoplasmic tail, 
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which in most cases is shorter than  50 amino acids.  Al- 
though several studies have identified functionally impor- 
tant  regions  within  the  integrin  ectodomain  (Smith  and 
Cheresh, 1988, 1990; D'Souza et al., 1988, 1990, 1994; Lof- 
tus et al., 1990; Takada et al., 1992; Lee et al., 1995) and cy- 
toplasmic domain (Hibbs et al., 1991; O'Toole et al., 1991, 
1995; Bauer et al., 1993; Filardo and Cheresh,  1994) that 
can  regulate  ligand-binding  function,  relatively  little  is 
known regarding structural motifs within the integrin that 
regulate  morphological  changes  in  cell  shape  which  ac- 
company cellular adhesion and migration. 
Several observations indicate that, upon ligand binding, 
the integrin cytoplasmic tail mediates a physical interac- 
tion  with  cytoskeletal proteins  (Otey et  al.,  1990, 1992; 
Miyamoto et al., 1995). These interactions  are presumed 
to  promote  the  organization  of  the  actin  cytoskeleton 
leading to changes in cellular structure  and morphology 
associated with integrin receptor clustering at focal con- 
tacts.  Moreover,  several  studies  have  reported  that  se- 
quences within the 13 subunit cytoplasmic tails may play a 
role in the recruitment  of integrins  to cell-substrate  at- 
tachment  sites  (Hayashi et al.,  1990; La Flamme  et  al., 
1992; Reszka et al., 1992; Yl~inne et al., 1993; Cone et al., 
1994). These sequences represent regions of structural ho- 
mology between the  individual  integrin  13 subunit  cyto- 
plasmic  tails  including  a  membrane-proximal  sequence 
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served sequences, NPXY and NXXY, that comprise tight 
13 turns. While these regions have been linked to the ability 
of integrins to localize to focal contacts, little is known 
about these domains in terms of postligand binding events. 
Integrin ctv133 is highly expressed on various motile cells 
in vivo, including neural crest cells (Delannet et al., 1994), 
vascular endothelial cells (Brooks et al., 1994a,b),  and ma- 
lignant melanoma cells (Albelda et al.,  1991). Therefore, 
to define structural regions within the 133 cytoplasmic taft 
that are required for av133 post-ligand binding function, 
we utilized a hamster cell line, CS-1,  that fails to express 
endogenous 133  or  [35  subunit proteins,  and as  a  conse- 
quence does not display any vitronectin receptors on its 
surface  (Thomas  et  al.,  1993).  Upon  transfection  of  a 
cDNA-encoding wild-type 133 subunit protein, these cells 
express av133 enabling them to attach, spread, and migrate 
in response to vitronectin. Moreover, these cells gain the 
ability to form pulmonary metastases in the chick embryo 
after  being  grown  on  the  chorioallantoic  membrane 
(CAM) 1. In contrast, mutations that disrupt the NPXY se- 
quence (amino acids 744-747) present in the 133 cytoplas- 
mic tail maintain their capacity to bind soluble ligand yet 
are unable to promote etv133-dependent cell morphological 
changes that are prerequisite for cell motility both in vitro 
and during tumor cell metastasis in vivo. 
Materials and Methods 
Cell Culture 
The CS-1 hamster melanoma cell line was originally described by Knud- 
sen et al., 1982. These cells do not express av133 or av135 vitronectin recep- 
tors, since they fail to express 133 or 135, and as a consequence are nonad- 
herent when cultured in the presence of serum (Thomas et al., 1993). CS-1 
cells were propagated in RPMI media supplemented with 5% FBS, 2 mM 
L-glutamine, and 50 p,g/ml gentamicin. 
cDNA Constructs 
Mutant and wild-type integrin 133 subunit proteins were generated from a 
molecular clone, p133GEM-1, containing a 3.8-kb EcoRI cDNA fragment 
encoding a full-length human 133 polypeptide (Fitzgerald et al., 1987). 
To  express  wild-type  133  polypeptide,  the  EcoRI  ends  of the  3.8-kb 
p133GEM-1  cDNA  fragment were  filled in  with Klenow enzyme, and 
blunt-end  ligated  into  the  EcoRV  site  within  the  polylinker  of  the 
pcDNA-lneo vector (Invitrogen, La Jolla, CA). To facilitate the construc- 
tion  of cDNAs  encoding mutant  133  cytoplasmic tails,  an  expression 
cassette  encoding  the  amino-terminal  two  thirds  of  the  133  subunit 
polypeptide was created within the pcDNA-lneo expression vector. An 
oligonucleotide containing a HindIII restriction site, d(CCAAGCTTGG), 
was inserted into the 5'  EcoRI site of the p133GEM-1  eDNA and the 
1,500-bp  HindIII-BamHI  133  fragment  was  directionally  cloned  into 
pcDNA-lneo to generate pH3Bm1.5133neo. 
Truncated 133 subunit proteins are named based upon the position of 
their COOH-terminal amino acid residue with respect to the mature 133 
polypeptide and are designated by the symbol A. To construct cDNAs en- 
coding 133.751 A- and 133.741 A-truncated polypeptides, cDNA fragments 
were amplified from linearized p133GEM-1 plasmid DNA by PCR using 
an upstream sense primer corresponding to nucleotides (nts) 2139-2165 
and downstream anti-sense primers 5' CTAGTCTAGACTAGGTGGC- 
CTCTTTATACAGTGGGTFG  3', 133.751(A) and 5' CTAGTCTAGAC_..: 
T._A_AGGTGTCCCAITITGCTCTGGCGCGTTC  3',  133.741(A) contain- 
ing nts 2295-2320  and  2327-2351,  respectively. In  addition to the 133- 
derived nucleotides, the downstream primers were designed to introduce 
1.  Abbreviations  used  in  this  paper:  CAM,  chorioallantoic membrane; 
LIBS, ligand induced binding site; nt, nucleotide; WT, wild-type. 
an amber stop codon (underlined) and an XbaI restriction endonuclease 
recognition site (bold) in order to facilitate the exchange of these PCR 
fragments  into  the  pcDNA-lneo  vector.  EcoRI-XbaI-restricted PCR 
fragments encoding the truncated cytoplasmic tails were then purified by 
electrophoresis through 8% nondenaturing acrylamide gels, and ligated in 
a ternary reaction with a 774-bp BamI-II-EcoRI fragment encoding the re- 
mainder of the ectodomain and the transmembrane anchor nt 1500-2274 
and BamHI-XbaI-digested pH3Bml.5133neo. 
Alanine or phenylalanine substitution mutants are designated by the 
position of the amino acid residue at which the substitution has been in- 
troduced into the wild-type 133 polypeptide. The first letter following the 
number indicates the original residue and the second letter following the / 
denotes the substituted one. To create a mutagenesis cassette, the 1336- 
kb BamHI-SacI fragment encoding the carboxyl-terminal one third of the 
133 subunit protein, nt 1500-2636,  was subcloned into pTZ18U (U.S. Bio- 
chem. Corp., Cleveland, OH). The 3' SacI site at nt 2636 in the untrans- 
lated region was converted to an XbaI site by the insertion of a synthetic 
oligonucleotide d(CTAGTCTAGACTAG)  (New England Biolabs, Bev- 
erly, MA) to create 18U1331.1X. Amino acid substitutions were produced 
by oligonucleotide mutagenesis of uracylated phagemid DNA prepared 
from  18U1331.1X as described by Filardo  and  Cheresh (1994).  Mutant 
cDNA clones were identified by DNA sequence analysis using the dide- 
oxynucleotide chain termination method (Sanger et al., 1977). Mutagenized 
1136-bp Bam_HI-XbaI fragments were isolated and ligated to Bam HI-XbaI- 
digested pH3Bml.5133neo  to generate  cDNAs encoding full-length 133 
polypeptides containing individual point mutations within the cytoplasmic 
tail. 
Monoclonal Antibodies 
mAb LM609 (ctv133) has been previously described (Cheresh and Spiro, 
1987). mAb AP3, specific for the human 133 subunit, was a generous gift of 
Dr. Peter Newman (Blood Center of Southwestern Wisconsin, Milwau- 
kee, WI). Fluoresceinated ligand induced binding site (LIBS)-I detects a 
conformer-specific  epitope on 133 integrins (Frelinger et al., 1990) and was 
kindly provided by Dr. Mark Ginsberg (Scripps Research Institute, La 
Jolla,  CA). mAb 7E2  specific for hamster 131  integrins was graciously 
provided by Dr. Rudolph Juliano (University of North Carolina, Chapel 
Hill, NC). 
Transfection  and Selection of Stable fl3-expressing 
Cell Lines 
133-deficient CS-1 cells were transfected with pcDNA-lneo constructs en- 
coding cDNAs encoding full-length or mutated versions of the 133 subunit 
protein  using lipofectin (GIBCO  BRL,  Gaithersburg,  MD).  3  d  after 
transfection, 500 i.Lg/ml of geneticin (Sigma Chemical Co., St. Louis, MO) 
was added to the growth medium. Transfected cells expressing mutant or 
wild-type 133 integrins were enriched from the geneticin resistant popula- 
tion by fluorescence activated ceil sorting using 133-specific mAb, AP3. 
Transfectants were sorted based on their mean intensity fluorescence, 
where the highest staining (0.5%) cells were gated under sterile condi- 
tions, expanded in culture,  and then resorted. This procedure was re- 
peated  until  stable  cell  lines were  obtained that  displayed equivalent 
amounts of wild-type or mutated 133 integrins on their surface. The integ- 
rity of each mutation within the 133 cytoplasmic tail was verified by nucleo- 
tide sequence determination of PCR products generated from polyadeny- 
lated  RNA  synthesized in  each  transfected cell  line.  Throughout  the 
course of these studies, all cell lines were maintained free of mycoplasma. 
Ligands and Cellular Adhesion Assays 
Vitronectin was purified from human serum as previously described (Ya- 
tohgo et al., 1988). Mouse laminin was purchased from Upstate Biotech- 
nology, Inc. (Lake Placid, NY). Cellular adhesion assays were performed 
as previously described (Klemke et al., 1994). 
Spreading on lntegrin  Specific Antibodies 
Glass coverslips (12 mm, No.1 thickness) were coated with 20 p,g/ml goat 
anti-mouse immunoglobulin (Southern Biotechnology Associates, Bir- 
mingham, AL) for 1 h at room temperature, Coverslips were then washed 
twice in PBS, and blocked with 1% heat denatured BSA for 1 h at 37°C. 
The wells were then washed with PBS and incubated in 10 I~g/ml of AP3 
mAb for 1 h at room temperature, and washed twice in adhesion buffer. 
133 transfected cells were seeded at a density of 100,000 cells/ml and incu- 
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using  a  microscope  equipped with  phase  contrast  (Nikon  Inc.,  Instr. 
Group, Melville, NY). 
RGD-induced LIBS-1 Expression 
CS-1 transfectants expressing wild-type or mutant 133 integrins were ana- 
lyzed for RGD-induced LIBS-1  expression as previously reported (Fi- 
lardo  and Cheresh, 1994).  GRGDSPK  and  SPGDRGK peptides were 
provided by E. Merck (Darmstadt, Germany). 
Cellular Migration Assays 
Cell migration assays were performed using modified Boyden chambers 
containing polycarbonate membranes (tissue culture treated, 6.5-p~m di- 
ameter, 10-p~m  thickness, 8-lxm pore, TransweU; Costar Corp., Cambridge, 
MA).  Migration toward immobilized adhesive ligand  (haptotaxis) was 
measured as described by Klemke et al. (1994). Migration toward soluble 
ligand (chemotaxis) was assessed in a similar manner. Except in this case, 
the undersurface of the membrane and all surfaces of the lower reservoir 
were preblocked with BSA. Excess BSA was removed and the lower res- 
ervoir was filled with 0.5 ml of FBM containing vitronectin or laminin (10 
I~g/ml). Cells that migrated into the lower chamber were enumerated by 
counting the number of cells on the floor of the lower reservoir per 200× 
field. 
Chick Embryo Metastasis Assay 
The chick embryo metastasis assay was performed as previously described 
with some minor modifications (Brooks et al., 1993).  Five million CS-1 
melanoma cells expressing wild-type or mutant 133 integrins were depos- 
ited on the CAM of 10-d-old chick embryos and incubated at 39°C in a hu- 
midified atmosphere. After i  wk, tumors formed at the primary site were 
excised, trimmed free of surrounding CAM tissue, and wet weights were 
determined. Tumor invasion was assessed by determining the percentage 
of melanoma cells present in a single cell suspension of whole lung tissue 
by flow cytometry using mAb 7E2, specific for hamster 131 integrins. 
Results 
Residues 742-751 within the f13 Cytoplasmic Tail 
Are Required  for av133-dependent Cellular Adhesion 
and Spreading 
Comparison of the cytoplasmic tail sequences of the indi- 
vidual  integrin  13  subunits  reveals  a  striking  degree  of 
structural homology. A structural motif common to six of 
the eight 13 subunit cytoplasmic tails is the presence of two 
well-conserved predicted tight 13 turns (see Fig. 1). One of 
these 13 turns, defined by the NPXY sequence, has been 
shown to have an influence on the recruitment of trans- 
fected integrins into preformed focal contacts (Reszka et 
al., 1992; Cone et al., 1994). Therefore, to address the in- 
fluence of the NPXY sequence with respect to its function 
in  regulating  integrin-mediated  adhesion,  we  examined 
the effect of mutations that eliminate the NPXY structural 
motif from the cytoplasmic domain of integrin etv133. 
The adhesive properties  of cells expressing av133 con- 
taining full-length or truncated 133 subunit proteins were 
characterized  by assessing the relative capacities  of the 
133.741 (A),  133.751 (A), and 133.762 (WT) cell lines to ad- 
here to polystyrene wells coated with varying concentra- 
tions  of vitronectin or  the  control protein,  laminin.  As 
shown in Fig. 2 A, nontransfected CS-1 cells, lacking otv133, 
were  incapable of attaching to vitronectin, yet attached 
well to the laminin-coated surface, consistent with their 
expression of 131 integrins (Thomas et al., 1993). CS-1 cells 
expressing etv133 composed of [~3.762 (wild-type) or 133.751 
~1  IIHDRREFAKFEKEKMNAKWDTGE NPIT  KSAVTTVV ~PKY  EGK 
HLSDLREYRRFEKEKLKSQWNND-  NPLF  KSATTTVM R~KF  AES 
~3  TIHDRKEFAKFEEERARAKWDTAN NPLY  KEATSTFT  JF/TY  RGT 
TIHDRREFAKFQSERSRARyEMAS  NPLT  P~KPISTHTVDFTFNKF ~  NGTVD 
SFHDRKEVAKFEAERSKAKWQTGT ~  RGSTSTFK  ~  KHREKQKVDLSTDC 
~7  EIYDRREYSRFEKEQQQLNWKQDS  NPLY  KSAITTTI  NPRF  QEADSPTL 
Figure 1.  Alignment of the deduced amino acid sequences of sev- 
eral integrin 13 subunit cytoplasmic tails. The deduced amino acid 
sequences of the 13 subunit cytoplasmic tails listed above are ob- 
tained from the following published data: 131 (Argraves et al., 
1987), 132 (Kishimoto et al., 1987), 133 (Fitzgerald et al., 1987), 1~5 
(McLean et al., 1990), 66 (Sheppard et al., 1990), and 137 (Erie et 
al., 1991). For each 13 subunit, the first amino acid listed is the res- 
idue that follows the transmembrane anchor. Residues compris- 
ing the tight 1~ turns encoded by the NPXY (underscored) and 
NXXY (italicized) sequences are denoted. 
(A) polypeptides adhered and spread well on vitronectin, 
indicating that elimination of 11  COOH-terminal amino 
acids, including the NXXY predicted 13 turn (residues 756- 
759) had little, if any, effect on otv133-mediated cell attach- 
ment. Adhesion of either of these 133-transfected  cells to 
vitronectin was completely inhibited by mAb LM609 dem- 
onstrating that etv133 is responsible for this event (Filardo, 
E. J., and D. A. Cheresh, unpublished data). In contrast, 
CS-1 ceils displaying otv133 containing the 133.741 (A)-trun- 
cated subunit protein failed to attach to the vitronectin 
substrate, while they readily attached to laminin. These re- 
suits suggest that the sequence between Thr  741  and Ala  75° 
is required for etv133-mediated cell attachment to immobi- 
lized vitronectin. 
Cellular adhesion to planar surfaces is greatly strength- 
ened by cell spreading (Lotz et al., 1989). Therefore, to es- 
tablish whether the failure of CS-1 cells expressing 133.741 
(A) to attach to a vitronectin substrate may be due in part 
to an inability of these cells to organize their actin cyto- 
skeleton and promote changes in cell shape, cells express- 
ing wild-type or mutant av133 were allowed to attach to 
coverslips coated with mAb AP3, specific for the 133 sub- 
unit protein. As shown in Fig. 2 B, all cell lines expressing 
av133 attached to the anti-133 antibody, but only etv133.762 
(WT) and etv133.751 (A) cells were able to spread on this 
ligand.  In  contrast, av133.741 (A)  cells  attached but  re- 
mained rounded, indicating their inability to engage the 
cytoskeleton and promote a shape change. These data sug- 
gest that amino acids 742-751  of the 133 subunit play a crit- 
ical role in regulating etv[33-dependent cell spreading, and 
may explain why cells expressing this form of etv133 fail to 
maintain an adherent phenotype on vitronectin. 
Residues Asn 744 or Tyr 747 within the NPXY 
Sequence in the [33 Cytoplasmic Tail Are Essential  for 
avfl3-dependent  Cellular Shape Changes 
Theoretical  calculations  that  predict  protein  secondary 
structure (Chou and Fasman, 1978; Rose, 1978)  indicate 
that the NPXY sequence within the integrin 13 subunit cy- 
toplasmic tails forms a tight turn. To determine whether 
this structural motif, defined by residues Asn744-Tyr  747 of 
the  133  cytoplasmic tail, is necessary for o~v133-mediated 
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Figure 2.  The effect of 133 truncation on CS-1 cell attachment to 
vitronectin.  (A)  CS-1  cells  expressing  ctv133 consisting  of full- 
length  (133.762)  or  truncated  (133.751A or  133.741A)  [33  subunit 
proteins were allowed to attach for 2 h to wells coated with vary- 
ing concentrations of vitronectin or laminin. After adhesion, un- 
attached  cells were removed by washing, and the attached  cells 
were stained with crystal violet. Cell attachment was quantified 
by spectrophotometric  analysis at OD 600 nm of the crystal violet 
dye eluted from the adherent cells. Each data point represents 
the mean  _+  the standard  deviation  of quadruplicate  samples. 
Nonspecific cell adhesion as measured on BSA-coated wells has 
been subtracted. (B) Phase-contrast micrographs of CS-1 cells ex- 
pressing  wild-type, 133.762 (WT)  or truncated,  133.751 (A) and 
[33.741 (A) polypeptides plated on 10 p~g/ml of either vitronectin 
or anti-133 mAb, AP3. 300×. Bar, 10 txm. 
cellular adhesion to vitronectin, individual amino acid res- 
idues  within  this  region  were  substituted  by  alanine- 
scanning  mutagenesis.  The  adhesive  properties  of  cells 
expressing o~v[33 containing single alanine substitution be- 
tween amino acid residues 741-750 in the [33 subunit cyto- 
plasmic tail were examined on varying concentrations of 
immobilized vitronectin. As shown in Fig. 3 A, CS-1  cells 
expressing av[33 with alanine substitutions in residues im- 
mediately upstream, Ash  743 or downstream, Lys  748 of the 
NPXY 744-747 sequence, exhibited vitronectin adhesion ac- 
tivity comparable to cells expressing wild-type av[33. Simi- 
larly, conversion of Pro  745 to an alanine had no effect on 
vitronectin  binding.  In  contrast,  replacement  of Asn  TM 
with an alanine resulted in a total loss of vitronectin adhe- 
sion behaving identically to truncation mutant [33.741 (A) 
(Fig. 2). This mutant cell line did not adhere to surfaces 
coated with as much as 20 ~g/ml of vitronectin (data not 
shown). In addition, an alanine substitution in Tyr  747 ex- 
hibited a  substantial but not complete loss in vitronectin 
adhesive activity (Fig. 3 A). The finding that two indepen- 
dent point-mutations in noncontiguous residues within the 
NPXY  sequence impacted vitronectin adhesive function 
suggests  that the structural integrity of this region is re- 
quired for [33 integrin function. 
Reduced vitronectin adhesivity displayed by av133.747 
Y/A cells may be due either to alterations in the structure 
of this region or a loss of phosphorylation at this site. To 
address this issue, the tyrosine at position 747 was substi- 
tuted with phenylalanine, an amino acid which is structur- 
ally homologous to tyrosine, but lacks the hydroxyl group 
which is the acceptor site for phosphorylation. As shown 
in  Fig.  3 A,  cells expressing etv[33.747 Y/F  containing a 
phenylalanine  in  place  of Tyr  747  exhibited wild-type vi- 
tronectin adhesion, supporting the idea that it is the struc- 
ture of this region rather than its phosphorylation status 
that is essential for adhesion to this substrate. 
These same point mutants were examined for their abil- 
ity to spread on immobilized anti-[33  antibody.  Cells ex- 
pressing uv[33 containing individual amino acid substitu- 
tions  that  were capable  of adhering to vitronectin were 
able to spread on this substrate or anti-[33 antibody (Fig. 3 
B). Conversely, point mutants defective in their capacity 
to adhere to vitronectin (Fig. 3 A) were unable to spread 
on  immobilized  anti-J33  antibody  (Fig.  3  B),  consistent 
with their inability to engage the actin cytoskeleton and 
mediate alterations in cell shape. Collectively, these find- 
ings demonstrate that the structure defined by the NPXY 
sequence within the [33 cytoplasmic tail is required to in- 
duce ctv[33-dependent cellular shape change. 
Effect of  Mutations within the ~3 Cytoplasmic 
Tail on Cell Interaction with Soluble Vitronectin or 
an RGD Peptide 
To determine whether mutations within the [33 NPXY se- 
quence may alter the ligand binding properties of av[33, 
cells expressing these mutant receptors were examined for 
their ability to bind soluble ligand. Ligand occupancy of [33 
integrins can be measured by a conformational change in 
the  [33  subunit  as  detected  by  the  LIBS-1  monoclonal 
antibody (Frelinger et al.,  1990). Therefore, expression of 
the  LIBS-1  epitope on etv[33.741 (A),  etv[33.744 N/A,  or 
av133.762 (WT) cells was measured in the presence or ab- 
sence of soluble GRGDSPK heptapeptide, a known ligand 
for av[33 (Spiro and Cheresh, 1987). As shown in Fig. 4 A, 
all three cell lines expressed equivalent LIBS-1 reactivity 
in the presence of 500 IxM GRGDSPK peptide, yet failed 
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Figure 3.  Adhesive properties of CS-1 cells expressing av133 with 
alanine or phenylalanine substitutions within the 133 subunit cyto- 
plasmic tail.  (A)  CS-1 cells expressing  av133-containing amino 
acid substitutions  in the residues  encompassing the 13 turn en- 
coded by the NPXY sequence (744-747) in the 133 subunit cyto- 
plasmic tail were allowed to attach for 2 h to wells coated with 10 
p.g/ml of vitronectin (black) or laminin (gray). After adhesion, 
the  attached cells were quantified  as  described  in  Fig. 2.  (B) 
Phase-contrast  micrographs of CS-1 cells expressing 133 polypep- 
tides containing individual amino acid substitutions, 133.744 N/A, 
133.747 Y/A, or 133.747 Y/F plated on coverslips coated with either 
vitronectin or anti-133 mAb, AP3. 300x. Bar, 10 txm. 
to show LIBS-1 binding in the presence of the same con- 
centration of the scrambled control peptide SPGDRGK. 
More importantly, each of these [~3-transfected cell lines 
showed an equivalent RGD dose-dependent LIBS-1 acti- 
vation with half-maximal concentrations between 1 and 2 
~M, suggesting that RGD binds to each of these receptors 
with  comparable  affinity (Fig.  4  B).  We  next examined 
whether intact soluble  vitronectin binding  to  these  cells 
would induce expression of the LIBS-1 epitope. As dem- 
onstrated  in  Fig.  4  C,  av133.741A,  av1~3.744 N/A,  or 
av133.762  (WT)  cells  bound  soluble  vitronectin as  mea- 
sured by LIBS-1 expression. These data demonstrate that 
mutations in the 133 cytoplasmic tail that eliminate or dis- 
rupt the NPXY sequence abolish av[~3 cell attachment to 
immobilized vitronectin, yet do not perturb the ability of 
av133 to interact with soluble ligands. 
The Role of the [33 NPXY Sequence in Melanoma Cell 
Motility In Vitro and Metastasis In Vivo 
Integrin otv133 has been shown to promote tumor cell mi- 
gration (Leavesley et al., 1992). Therefore, to investigate 
the role of the 133 NPXY sequence in cell motility, cells ex- 
pressing wild-type or mutant o~v133 were tested for their 
chemotactic or haptotactic response to soluble or immobi- 
lized vitronectin, respectively. As shown in Fig. 5, A and B, 
CS-1 cells lacking etv133 fail to migrate toward soluble or 
immobilized vitronectin while they readily migrate in re- 
sponse to the control protein laminin. Cells expressing ei- 
ther av133.762 (WT) or av133.751 (A) acquire the ability to 
migrate  toward  lower chambers  coated with vitronectin 
(Fig. 5 A) or containing soluble vitronectin (Fig. 5 B). In 
contrast, CS-1 cells expressing av1~3.741 (A) fail to migrate 
in response to either immobilized or soluble vitronectin. 
These  findings  demonstrate  that  although  the  av133.741 
(a)  cells  bind  soluble  vitronectin,  they  are  unable  to 
chemotax toward this protein. 
Integrin-mediated cell motility events have been linked 
to cell invasion in vivo (Juliano, 1987; Cheresh, 1991). Fur- 
thermore,  expression of ~v133 on the  surface  of human 
melanoma cells has  been associated with tumorigenicity 
and progression toward malignancy (Albelda et al.,  1991; 
Felding-Habermann et al., 1992; Nip et al., 1993).  To ex- 
amine whether the NPXY  sequence within the  133 cyto- 
plasmic tail can regulate cellular migration in vivo, CS-1 
cells expressing wild-type or mutant av133 were examined 
for their growth and metastatic properties in the chick em- 
bryo model  (Brooks et  al.,  1993).  CS-1  melanoma  cells 
were deposited onto the CAM of 10-d-old chick embryos 
and allowed to grow for 1 wk, after which the primary tu- 
mor nodule was surgically excised and weighed. In addi- 
tion, the lungs were harvested, and a single cell suspension 
was  prepared by collagenase  treatment.  Pulmonary me- 
tastasis was quantified by determining the percentage of 
tumor ceils present in this cell suspension by staining with 
a  monoclonal  antibody  specific  for  hamster  cells.  As 
shown in Fig. 6, CS-1 cells lacking av133, formed large tu- 
mors at the primary site, yet these animals contained few, 
if any,  detectable  tumor  cells  in  the  lungs.  In  contrast, 
e~v133.762  (WT)  cells  produced  small  primary  tumors 
which, on average, were fivefold smaller than CS-1 tumors 
(Fig. 6 A). However, as shown in Fig. 6 B, this lack of pri- 
mary tumor size was associated with an approximate five- 
fold increase in  pulmonary metastasis  (P  ~<  0.001),  sug- 
gesting that  expression of etv133 on CS-1  cells promoted 
migration from the primary tumor site. In contrast, cells 
expressing av133.744 N/A (Fig. 6) or 133.747 Y/A (data not 
shown), which exhibited deficient migration in vitro, pro- 
duced tumors whose growth properties and metastatic be- 
havior were identical to the parental, av133-negative CS-1 
cell line.  CS-1  cells expressing avB3.747  Y/F  possessing 
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Figure 4.  Soluble RGD peptide or vitronectin increases LIBS-1 
expression  on  133.762 (NNPLYK),  133.744 (NAPLYK)  and 
133.741(A) cell lines.  Histograms generated from flow cytometry 
analysis  of CS-1 cell lines  expressing wild-type or mutant c~v133. 
Cells  were stained with fluorescein-labeled LIBS-1 in the pres- 
ence of either (A) 500 p,M of either GRGDSPK (solid) or scram- 
bled SPGDRGK (open) heptapeptide or (B) 5 IxM of soluble vi- 
tronectin (solid) or bovine serum albumin (open). The x-axis val- 
ues are displayed on a logarithmic scale as arbitrary fluorescence 
units and the y-axis values are on a  linear scale and represent 
number of cells. WT, wild-type.  Bold-face indicates the NPXY 13 
turn motif. The alanine substitution at position 744 is underscored. -e-, 133.762 (WT); -A-, 133.741 (A); -[3-, 133.744 N/A. (C) Line graph 
derived from flow cytometry analysis of cells stained with fluoresceinated LIBS-1 antibody in the presence of varying concentrations of 
GRGDSPK peptide. The x-axis values are displayed on a logarithmic scale as arbitrary fluorescence units and the y-axis values are on a 
linear scale and represent the percentage of the increase in LIBS-1 expression between no peptide and 500 p,M of GRGDSPK. 
wild-type  migration  properties  in  vitro,  completely  re- 
stored  the  metastatic  phenotype  of these  cells.  The  ob- 
served inverse correlation between the size of the primary 
tumor and its ability to metastasize suggests that CS-1 cells 
lacking  the  metastatic  phenotype  are  unable  to  migrate 
from  the  primary  lesion.  In  support  of this  contention, 
o~v[33 with mutations that disrupt CS-1 melanoma cell mo- 
tility in  vitro  also prevent  pulmonary metastasis  in  vivo. 
Collectively, these data provide evidence that the NPXY 
sequence within the [33 cytoplasmic tail is a  critical struc- 
ture in regulating cellular migration in vitro and in vivo. 
Discussion 
Integrin-mediated  adhesion  events  are  associated  with  a 
wide range of biological activity both in vitro and in vivo. 
In fact, integrin gene "knock-outs" lead to embryonic le- 
thal mutations (Yang et al., 1995) and altered cell biologi- 
Figure 5.  Cell migration of CS-1 cells expressing etv133 consisting of full-length or truncated 133 polypeptides. Cellular motility toward 
vitronectin or laminin was determined using a modified Boyden chamber separated by a 6.5 ~m porous membrane. CS-1 (white), 133.762 
(WT) (black), 133.751 (A) (gray), or 133.741 (A) (hatched) cells were seeded into the upper chambers and allowed to migrate for 24 h to- 
ward lower chambers containing 10 p,g/ml of immobilized adhesive ligand (haptotaxis) (A) or soluble ligand (chemotaxis) (B).  Cells 
which had migrated to the lower reservoir were enumerated by dye uptake (A) or by microscopic evaluation (B) as described in the ex- 
perimental procedures. Each bar represents the mean __+ the standard deviation of quadruplicate samples. 
The Journal of Cell Biology, Volume 130, 1995  446 cal responses (Stephens et al., 1993) while integrin antago- 
nists  block  platelet  aggregation  (Savage  et  al.,  1990), 
tumor cell migration (Humphries et al., 1986), angiogene- 
sis (Brooks et al., 1994),  and viral infection (Wickham et 
al., 1993). The biological role of integrins depends on their 
ability to bind extracellular matrix proteins resulting in the 
generation  of  intracellular  signals.  This  leads  to  cell 
spreading and migration, events which have been linked to 
the organization of the actin cytoskeleton (Burridge et al., 
1988). Therefore, it has been proposed that ligand recogni- 
tion by integrins leads to structural alterations in the inte- 
grin  cytoplasmic  domain  facilitating postligand  binding 
events important for cell spreading and motility. While ex- 
tensive studies have identified sequences within the extra- 
cellular  domain  of integrins  involved in  ligand  binding 
(Smith and Cheresh, 1988, 1990; D'Souza et al., 1988, 1990; 
1994; Loftus et al., 1990; Takada et al., 1992; Lee et al., 
1995),  little is known about the structural regions within 
the integrin cytoplasmic domain that mediate postligand 
binding events. 
Integrin otv63 is highly expressed on various motile cell 
types in vivo. For example, this integrin is preferentially 
expressed  on  invasive  melanoma  cells  (Albelda  et  al., 
1991; Nip et al., 1993), angiogenic vascular cells (Brooks et 
al., 1994a,b)  and on migratory neural crest cells (Delannet 
et al., 1994). Also, integrin otv63 readily promotes migra- 
tion of primary endothelial cells or various transformed 
cells in vitro (Leavesley et al., 1992, 1993). Therefore, we 
designed experiments to identify regions within the cyto- 
plasmic domain of av63 that were involved in the cell mo- 
tility response. To accomplish this objective, we used CS-1 
melanoma cells that fail to express any vitronectin binding 
integrin due to their lack of 63 or 65 protein. We show in 
this report that cells transfected with a  cDNA encoding 
full-length 63 express av63 and thereby gain the ability to 
attach, spread, and migrate on a vitronectin substrate. To 
identify functional domains within the 63 cytoplasmic tail 
critical for these  vitronectin adhesion  events,  CS1  cells 
were transfected with truncated or mutant forms of 63. In 
particular,  we  focused on  two  structural motifs, NPXY 
(744-747)  and NXXY  (756-759),  which are predicted to 
form 6 turns in the cytoplasmic tails of, not only [33, but 
most of the other integrin 6 subunits (Fig. 1). 
This mutational analysis of the 63 subunit demonstrates 
that disruption or elimination of the NPXY sequence pre- 
vents av63-dependent CS-1  cell attachment or migration 
on a vitronectin substrate. We provide evidence that these 
mutations  do  not  influence  the  soluble  ligand  binding 
properties  of  this  receptor  since  either  vitronectin-  or 
RGD-containing peptides  were  able  to  interact equally 
well with all mutant forms of otv63 tested. Therefore, we 
propose that mutations in the NPXY motif of 63 perturb 
postligand binding events involved in otv63-dependent cy- 
toskeletal assembly required for cell spreading and migra- 
tion  on  a  vitronectin substrate.  This  contention is  sup- 
ported by the finding that cells expressing a  mutant or 
deleted NPXY sequence attached, but failed to spread or 
migrate on immobilized anti-63 antibody. 
Prior reports have shown that mutations in the 6 subunit 
cytoplasmic  tail  impact  cell  adhesion  to  immobilized 
ligand. Mutations in the 62 subunit cytoplasmic tail abol- 
ish aL132-mediated cell adhesion to purified ICAM (Hibbs 
et al., 1991). More recently, it was shown that deletion of 
the NPXY sequence expressed in the context of the plate- 
let receptor otlIb63 altered the affinity state of this recep- 
tor for its ligand (O'Toole et al., 1995). Our studies suggest 
that NPXY mutations in av63 have little or no effect on 
the affinity of this receptor for soluble ligand as measured 
by LIBS epitope  expression in the presence  of varying 
concentration of soluble RGD. Rather, this mutation ap- 
pears to abolish the interaction of cells with immobilized 
ligand. These results may be explained by the inability of 
these mutant receptors to organize the actin cytoskeleton 
and promote a shape change on immobilized vitronectin 
or anti-63 antibody. 
The NPXY sequence is present in the cytoplasmic do- 
main of a  number of non-integrin receptors such as the 
low density lipoprotein receptor where it has been linked 
to receptor internalization sknce mutations in NPXY result 
in  reduced  receptor  internalization  (Chen  et  al.,  1990). 
CS-1  cells expressing etv63.741(A)  lacking the NPXY se- 
quence were tested for their ability to internalize integrin 
otv63 in response to cross-linking with anti-63 antibodies. 
Interestingly, both the wild-type and NPXY-deleted  re- 
ceptors showed equivalent internalization (Filardo, E. J., 
unpublished  data).  These  data  suggest  that  while  the 
NPXY is critical for the internalization of some cell sur- 
face receptors this motif does not appear to be required 
for etv63-dependent internalization. 
Integrin-mediated cell adhesion is characterized by inte- 
grin clustering at discrete membrane sites known as focal 
contacts,  which  serve  to  strengthen the  interaction be- 
tween cells and their substratum (Burridge et al., 1988). In 
fact,  focal  contacts  serve  to  tether  actin filaments  and 
stress fibers facilitating cell spreading. Based on previous 
studies, it is apparent that specific regions of the integrin 6 
subunit cytoplasmic domain are critical for focal contact 
assembly (Reszka et al., 1992; Cone et al., 1994). This pro- 
cess likely depends on the ability of the integrin cytoplas- 
mic tail to associate with various cytoplasmic protein such 
as  talin  and  a-actinin  (Tapley et  al.,  1989; Otey et  al., 
1992). In addition, there are several nonreceptor tyrosine 
kinases that are associated with focal contacts, including 
focal  adhesion  kinase,  pp125FAK  (Hanks  et  al.,  1992; 
Kornberg et al., 1992; Schaller et al., 1992), src kinase, pp60v- 
src (Rohrschneider et al., 1990), type IV c-abl kinase (Van 
Etten et al., 1994), as well as a variety of SH2- and SH3- 
containing proteins (Miyamoto et al., 1995). These obser- 
vations suggest that  the  integrin cytoplasmic domain is 
critical in recruiting signaling molecules that not only reg- 
ulate cell shape, but also impact other events such as cell 
migration, invasion, and proliferation. To this end, we ob- 
served that the same mutations in [33 that prevent cell mo- 
tility in vitro directly impact the metastatic properties of 
these cells in vivo. We showed that CS-1 melanoma cells 
lacking etv63 form large primary tumors when allowed to 
grow on the chick embryo CAM, yet these cells fail to es- 
tablish lung metastases in these animals. However, trans- 
fection of CS-1 cells with wild-type 63 enables them to in- 
vade and colonize the lungs of these animals. Interestingly, 
primary tumors comprised of otv63 expressing CS-1 cells 
are fivefold smaller than their nontransfected counterparts, 
suggesting that the  metastasis observed  was  due  to  the 
ability of CS-1 cells expressing etv63 to migrate from the 
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Figure 6.  Effect of individual amino acid substitutions  in the NPXY sequence  within the 133 cytoplasmic tail on tumor growth and me- 
tastasis. (A) Representative examples of tumors excised from 17-d-old chick CAM after seven d of growth. (B) Primary tumor weight 
and percentage of metastatic melanoma cells present in chick lung after 7 d of tumor growth. Tumor weight is expressed in rag. The per- 
centage of metastatic melanoma cells was determined by flow cytometry analysis of a single cell suspension prepared from whole lung 
using mAb, 7E2 specific for the hamster integrin  131 subunit. The difference in growth rate and metastasis are significant (P ~< 0.001) as 
determined by the Student t test. 
site of the primary tumor. This contention is supported by 
the fact that these cell lines show identical growth rates in 
culture (data not shown) suggesting that the observed dif- 
ference in the size of these primary tumors is not due to an 
intrinsic difference in the growth rate of these cells. More 
importantly, mutations  in  the  NPXY sequence  that  pre- 
vent cell motility in vitro, show minimal metastasis in vivo, 
while  forming  large  primary  tumors  identical  to  those 
formed  by otvl33-negative CS-1  cells.  These  findings  are 
consistent with the observation that vertically invasive pri- 
mary as  well  as  metastatic  human  melanoma tissue  ex- 
presses txv133, while noninvasive primary lesions lack etv133 
(Albelda  et  al.,  1991).  Moreover,  Nip  and  co-workers 
(1993)  showed  that  melanoma  cells  isolated  from nude 
mouse  metastases  express  elevated levels of etv133 com- 
pared with their primary tumor cell counterparts. 
The structural motif defined by the NPXY sequence in 
133  is  likely  to  play  a  major  role  in  other  integrin  het- 
erodimers since this motif is found in the same region of 
most other integrin  13 subunits.  However, it is clear from 
our studies that the NPXY motif in the 133 subunit regu- 
lates postligand binding events that are critical to cellular 
morphology and migration in vitro. More importantly, we 
provide the  first evidence of an integrin  structural  motif 
that plays a critical role in the metastasis of tumor cells in 
vivo. This is underscored by the finding that a single point 
mutation in the 133 subunit prevents av133-dependent cel- 
lular post-ligand binding events leading to the metastatic 
behavior of tumor cells in vivo. 
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